blocker approved for the treatment of chronic inflammatory demyelinating polyneuropathy or CIDP. CIDP is a progressive, immune-mediated rare and debilitating neuromuscular disorder of the peripheral ...

With that in mind, this study aimed “to determine whether cannabinoids are a potentially effective treatment for pain and ...

PRNewswire Bengaluru Karnataka [India]4 For many youngsters cancer remains an abstract and frightening concept that would ...

Medically reviewed by Sarah Richards, DPM A burning sensation in your feet can happen for several reasons. Knowing the exact ...

The company notes that you should slowly “wear in” your insoles by walking in them for a few days before taking them on a run ...

Arialief is a nerve health-supporting formula that has gained popularity in recent days. Similar to any other dietary ...

Vertex announces data from a phase II study evaluating its NaV1.8 pain signal inhibitor, suzetrigine, for treating painful lumbosacral radiculopathy. Shares down.

Lack of NaV1.7 activity leads to the inability to sense pain, whereas NaV1.7 gain of function leads to severe pain. Modulation of NaV1.7, therefore, should be an effective mechanism for decreasing ...